HC Wainwright Lowers Earnings Estimates for Envoy Medical

Envoy Medical, Inc. (NASDAQ:COCH) – Research analysts at HC Wainwright lowered their Q2 2026 earnings estimates for shares of Envoy Medical in a research report issued to clients and investors on Wednesday, July 15th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.09) per share for the quarter, down from their previous forecast of ($0.08). HC Wainwright currently has a “Buy” rating and a $2.50 target price on the stock. The consensus estimate for Envoy Medical’s current full-year earnings is ($0.29) per share. HC Wainwright also issued estimates for Envoy Medical’s Q3 2026 earnings at ($0.07) EPS and FY2026 earnings at ($0.29) EPS.

COCH has been the subject of several other research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Envoy Medical in a report on Friday, April 24th. Zacks Research raised Envoy Medical to a “hold” rating in a research note on Wednesday, April 1st. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Envoy Medical presently has a consensus rating of “Hold” and an average target price of $2.50.

Envoy Medical Trading Down 7.7%

Shares of NASDAQ:COCH opened at $0.70 on Friday. The firm has a fifty day moving average price of $0.69 and a 200 day moving average price of $0.68. The stock has a market capitalization of $53.94 million, a PE ratio of -0.69 and a beta of 1.88. Envoy Medical has a 1 year low of $0.36 and a 1 year high of $1.89.

Envoy Medical (NASDAQ:COCH) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.03. The business had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.10 million.

Institutional Trading of Envoy Medical

Hedge funds have recently bought and sold shares of the stock. DSG Capital Advisors LLC acquired a new position in shares of Envoy Medical in the first quarter valued at approximately $416,000. Focus Partners Wealth acquired a new stake in shares of Envoy Medical during the first quarter worth $276,000. CIBC Bancorp USA Inc. bought a new stake in Envoy Medical in the 3rd quarter valued at $60,000. Finally, Geode Capital Management LLC lifted its position in Envoy Medical by 111.3% in the 4th quarter. Geode Capital Management LLC now owns 98,351 shares of the company’s stock valued at $65,000 after acquiring an additional 51,813 shares in the last quarter. 8.59% of the stock is currently owned by institutional investors and hedge funds.

Envoy Medical News Roundup

Here are the key news stories impacting Envoy Medical this week:

• Negative Sentiment: HC Wainwright lowered its Q2 2026 EPS estimate for Envoy Medical to ($0.09) from ($0.08) and cut its Q3 2026 EPS estimate to ($0.07) from ($0.06), signaling slightly weaker profitability expectations. Article link
• Neutral Sentiment: The firm still kept a Buy rating and $2.50 price target on COCH, suggesting analysts remain constructive on the longer-term story despite the near-term estimate cuts. Article link
• Neutral Sentiment: HC Wainwright also slightly improved its FY2026 EPS forecast to ($0.29) from ($0.30) and projected FY2027 EPS of ($0.19), indicating losses are expected to narrow over time. Article link

Envoy Medical Company Profile

Envoy Medical (NASDAQ:COCH) is a medical device company focused on non-invasive neuromodulation therapies for dysphagia, a swallowing disorder that affects patients following neurological events or due to degenerative conditions. The company’s lead technology delivers targeted electrical stimulation designed to strengthen the muscles and neural pathways involved in the swallowing process.

Envoy Medical’s flagship therapy has received regulatory clearance from the U.S. Food and Drug Administration and is being introduced through rehabilitation centers, speech-language pathology clinics and acute care hospitals.